The authors would like to thank all of the patients who participated in the trials.
The trials (NCT01866163, NCT02132936, NCT01536886) and the journal’s Rapid Service Fee were funded by LEO Pharma, Ballerup, Denmark.
Medical Writing Assistance
The authors would like to acknowledge Bridie Andrews, MSc, of iMed Comms, Macclesfield, UK, an Ashfield company, part of UDG Healthcare plc, for medical writing support that was funded by LEO Pharma in accordance with Good Publications Practice (GPP3) guidelines (https://www.ismpp.org/gpp3).
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
The data in this manuscript contains data from three pooled trials, each of which has been previously published individually [9,10,11] and presented at the 28th European Academy of Dermatology and Venereology (EADV) Congress, 9–13 October 2019, Madrid.
Lars Iversen has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Centocor, Eli Lilly, Janssen-Cilag, Kyowa, LEO Pharma, MSD, Novartis, Pfizer and UCB. Merle Kurvits and Anja M. Snel-Prentø are employees of LEO Pharma, Ballerup, Denmark. Alan Menter has served as a consultant and/or paid speaker for and/or participated in clinical trials and/or participated in advisory boards sponsored by Abbott Labs, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Janssen Biotech Inc., LEO Pharma, Merck, Novartis, Sienna and UCB. Alan Menter is also a member of this journal’s Editorial Board.
Compliance with Ethics Guidelines
Approval was obtained from all relevant Institutional Review Boards and/or Independent Ethics Committees and Regulatory Authorities prior to the enrollment of patients. All patients provided written informed consent. The trials were conducted in accordance with the Declaration of Helsinki 1964, as revised 2013, concerning human and animal rights, Good Clinical Practice and Ethical Principles for Medical Research Involving Human Subjects.
The datasets generated during and/or analyzed during the current study are available from LEO Pharma on reasonable request subject to approval of a Patient and Scientific Review Board.